Literature DB >> 316688

Quantification of HTLA-positive lymphocytes during oral photochemotherapy of psoriasis.

D Schmitt, J P Ortonne, A Alario, J Thivolet.   

Abstract

T-lymphocyte count in the peripheral blood, based on the identification of anti-human lymphocyte antigen (HTLA) by an immunocytochemical method, was determined in 25 PUVA-treated psoriatics and in 25 controls matched by sex and age. The results demonstrate that the HTLA-positive lymphocyte counts of these two groups do not differ significantly. It is concluded that oral photochemotherapy does not induce quantitative modifications in the population of T-lymphocytes of the blood.

Entities:  

Mesh：

Substances：

Year:  1979        PMID： 316688     DOI： 10.1007/bf00418568

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


  10 in total

1.  Immunological aspects of psoriasis. II. Dissociated impairment of thymus-dependent lymphocytes.

Authors:  J J Guilhou; J Meynadier; J Clot; E Charmasson; M Dardenne; J Brochier
Journal:  Br J Dermatol       Date:  1976-09       Impact factor: 9.302

2.  Ultrastructural identification of human tonsil T-lymphocytes by peroxidase-conjugated anti-HTLA serum.

Authors:  D Schmitt; J Brochier; J P Révillard; J Thivolet
Journal:  Experientia       Date:  1976-09-15

3.  Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light.

Authors:  J A Parrish; T B Fitzpatrick; L Tanenbaum; M A Pathak
Journal:  N Engl J Med       Date:  1974-12-05       Impact factor: 91.245

4.  Impairement of thymus derived rosette forming cells during photochemotherapy (psoralen--U.V.A.).

Authors:  J P Ortonne; A Claudy; A Alario; J Thivolet
Journal:  Arch Dermatol Res       Date:  1978-07-28       Impact factor: 3.017

5.  Heterologous specific antiserum for identification of human T lymphocytes.

Authors:  J L Touraine; F Touraine; D F Kiszkiss; Y S Choi; R A Good
Journal:  Clin Exp Immunol       Date:  1974-04       Impact factor: 4.330

6.  Effects of 8-methoxypsoralen (8-MOP) and UVA on human lymphocytes.

Authors:  G Lischka; E Bohnert; G Bächtold; E G Jung
Journal:  Arch Dermatol Res       Date:  1977-09-27       Impact factor: 3.017

7.  Photochemotherapy for psoriasis with orally administered methoxsalen.

Authors:  K W Wolff; T B Fitzpatrick; J A Parrish; F Gschnait; B Gilchrest; H Hönigsmann; M A Pathak; L Tannenbaum
Journal:  Arch Dermatol       Date:  1976-07

8.  Toxic effects of 8-methoxypsoralen on lymphocyte division.

Authors:  H C Wulf; G Wettermark
Journal:  Arch Dermatol Res       Date:  1977-12-12       Impact factor: 3.017

9.  Dose-effects of 8-methoxypsoralen and UVA in cultured human lymphocytes.

Authors:  J Krüger; E Christophers; M Schlaak
Journal:  Br J Dermatol       Date:  1978-02       Impact factor: 9.302

10.  UVA-induced inhibition of proliferation of PHA-stimulated lymphocytes from humans treated with 8-methoxypsoralen.

Authors:  R Scherer; B Kern; O Braun-Falco
Journal:  Br J Dermatol       Date:  1977-11       Impact factor: 9.302
  10 in total
  1 in total

1.  Enhancement of cutaneous delayed hypersensitivity reactions by a single exposure to UV-A or PUVA.

Authors:  S Moberg; H Mobacken
Journal:  Arch Dermatol Res       Date:  1982       Impact factor: 3.017
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.